Alzheimer's drug approved despite murky results

被引：17
|
作者：
Servick, Kelly
机构：
来源：
SCIENCE | 2021年 / 372卷 / 6547期
关键词：
D O I：
10.1126/science.372.6547.1141
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1141 / 1141
页数：1
相关论文
共 50 条
  • [1] MURKY RESULTS FOR ALZHEIMER'S DRUGS
    Jarvis, Lisa
    [J]. CHEMICAL & ENGINEERING NEWS, 2015, 93 (30) : 10 - 10
  • [2] COMPENSATION STATUTE MURKY DESPITE RULING
    不详
    [J]. ENGINEERING NEWS-RECORD, 1983, 210 (03): : 149 - 149
  • [3] Lupus Drug Is Approved Despite Previous Clinical Trial Setback
    Kuehn, Bridget M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (11): : 1000 - 1000
  • [4] FDA approves controversial Alzheimer's drug despite uncertainty over effectiveness
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [5] New Alzheimer's drug clears FDA advisory vote despite unknowns
    Couzin-Frankel, Jennifer
    [J]. SCIENCE, 2024, 384 (6701) : 1164 - 1165
  • [6] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer’s disease treatment
    Jinwei Zhang
    [J]. Inflammation Research, 2023, 72 : 1873 - 1876
  • [7] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment
    Zhang, Jinwei
    [J]. INFLAMMATION RESEARCH, 2023, 72 (09) : 1873 - 1876
  • [8] New Alzheimer's drug approved by US FDA, sharply divides medical opinion
    Hussain, Maharra
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (05): : 319 - 320
  • [9] Crohn's drug approved
    不详
    [J]. CHEMISTRY WORLD, 2008, 5 (06): : 18 - 18
  • [10] Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression
    Mielke, Michelle M.
    Leoutsakos, Jeannie-Marie
    Corcoran, Chris D.
    Green, Robert C.
    Norton, Maria C.
    Welsh-Bohmer, Kathleen A.
    Tschanz, JoAnn T.
    Lyketsos, Constantine G.
    [J]. ALZHEIMERS & DEMENTIA, 2012, 8 (03) : 180 - 187
12345